(Q51307609)

3 April 2018

title

Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams. (English)

1 reference

3 April 2018

main subject

Brucella ovis

Brucella ovis

1 reference

1

1 reference

3 April 2018

Juan M. Irache

7

1 reference

3 April 2018

Carlos Gamazo

Carlos Gamazo

9

0 references

Maite Estevan

2

Maite Estevan

1 reference

3 April 2018

María Jesús Grillo

5

M Jesús Grilló

1 reference

3 April 2018

Montserrat Barberán

6

Montserrat Barberán

1 reference

3 April 2018

author name string

Clara M Marín

3

1 reference

3 April 2018

M Jesús De Miguel

4

1 reference

3 April 2018

Jose M Blasco

8

1 reference

3 April 2018

language of work or name

English

0 references

publication date

4 November 2005

1 reference

3 April 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

3 April 2018

volume

24

1 reference

3 April 2018

issue

11

1 reference

3 April 2018

page(s)

1897-1905

1 reference

3 April 2018

Immunization with Brucella melitensis Rev 1 against Brucella ovis infection of rams

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Brucella melitensis Rev-1 vaccine as a cause of human brucellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Microparticles as vaccine adjuvants and delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Measurement of protein using bicinchoninic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

STUDIES ON THE GRAM-NEGATIVE CELL WALL. I. EVIDENCE FOR THE ROLE OF 2-KETO- 3-DEOXYOCTONATE IN THE LIPOPOLYSACCHARIDE OF SALMONELLA TYPHIMURIUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Efficacy of different Rose Bengal and complement fixation antigens for the diagnosis of Brucella melitensis infection in sheep and goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Comparison of three serological tests for Brucella ovis infection of rams using different antigenic extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Comparison of polyclonal, monoclonal and protein G peroxidase conjugates in an enzyme-linked immunosorbent assay for the diagnosis of Brucella ovis in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Comparison of two selective media for the isolation of Brucella melitensis from naturally infected sheep and goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Cationic microparticles: A potent delivery system for DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Japanese encephalitis virus vaccine formulations using PLA lamellar and PLG microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Rough vaccines in animal brucellosis: structural and genetic basis and present status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

The microencapsulation of protein using a novel ternary blend based on poly(epsilon-caprolactone)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

inferred from DOI database lookup

7 January 2021

based on heuristic

Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.042

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.10.042

1 reference

3 April 2018

PubMed ID

16337315

1 reference

3 April 2018